Press Releases

Press Releases

Filters
Viatris Reports Second-Quarter 2026 Financial Results
Viatris Announces Quarterly Dividend
Viatris Receives U.S. FDA Approval for Gwyn Lo™, a Once-Weekly Contraceptive Patch
Viatris to Report Second-Quarter 2026 Financial Results on August 6, 2026
Viatris Announces Positive Top-Line Results from Phase 3 Study of VR-205 in Japanese Adults with Primary Immunoglobulin A Nephropathy
U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain
Viatris to Present at the Bank of America Securities 2026 Healthcare Conference
Viatris Reports First-Quarter 2026 Financial Results
Viatris Announces Quarterly Dividend
Viatris Announces Chief Financial Officer Transition
Displaying 1 - 10 of 198